B cell-mediated Immunity against Tuberculosis Infection: A Mini Review Study

Publish Year: 1398
نوع سند: مقاله ژورنالی
زبان: English
View: 502

This Paper With 6 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_RCM-6-4_002

تاریخ نمایه سازی: 26 خرداد 1399

Abstract:

Mycobacterium tuberculosis (Mtb) is considered to be a major public health concern and a successful intracellular pathogen associated with high mortality worldwide. The Bacillus Calmette-Guerin (BCG) vaccine is the only available vaccine for the prevention of tuberculosis (TB) and tubercular meningitis in children. However, BCG is not adequately effective in the treatment of the adults affected to TB. According to the literature, there are controversial data on the potential role of B cells. B cells and humoral immune response play a key role in the amplification of the host immune response against TB. This review study aimed to discuss B cells and humoral immune responses in TB infection and assess its application as a therapeutic option. The monitoring of various B cell phenotypes in TB could be a reliable marker for the prediction of TB in individuals, especially in the latent form. According to the findings, the CMI response (especially Th1 activities) is not sufficient for efficient protection against TB, and B cells and Abs influence the innate immunocytes and Th1, while playing a pivotal role in various outcomes of exposure with tubercle bacilli. Although B cells may contribute to Mtb in the development of active TB, further investigations are required regarding the effects of B cells and humoral immunity on TB pathogenesis and the targeted harmful humoral-mediated response. Moreover, B cells and antibodies could be proper biomarkers to promote the studies regarding the detection of reliable diagnostic tools for the reactivation of latent TB, as well as use as a new generation of therapeutic options.

Authors

Mohsen Karbalaei

Department of Microbiology and Virology, Faculty of Medicine, Jiroft University of Medical Sciences, Jiroft, Iran.

Saman Soleimanpour

Department of Microbiology and Virology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Majid Eslami

Cancer Research Center, Semnan University of Medical Sciences, Semnan, Iran.

Bahman Yousefi

Department of Immunology, Semnan University of Medical Sciences, Semnan, Iran.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Keikha M, Esfahani BN. The relationship between tuberculosis and lung ...
  • Eslami M. Comparison of culture and PCR methods for the ...
  • Youssefi M, Eslami M, Karbalaei M, et al. Autophagy as ...
  • Soleimanpour S, Farsiani H, Mosavat A, et al. APC targeting ...
  • Magis-Escurra C, Günther G Lange C, et al. Treatment outcomes ...
  • World Health Organization. Global tuberculosis control: surveillance, planning, financing: WHO ...
  • Eslami M, Shafiei M, Ghasemian A, et al. Mycobacterium avium ...
  • Shafiei M, Ghasemian A2, Eslami M, et al. Risk factors ...
  • Keikha M, Shabani M, Navid S, et al. What is ...
  • Getahun H, Matteelli A, Chaisson RE, et al. Latent Mycobacterium ...
  • Keikha M, Soleimanpour S, Eslami M, et al. The mystery ...
  • Pieters J. Mycobacterium tuberculosis and the macrophage: maintaining a balance. ...
  • Achkar JM, Casadevall A. Antibody-mediated immunity against tuberculosis: implications for ...
  • Achkar JM, Chan J, Casadevall A. B cells and antibodies ...
  • Roy E, Stavropoulos E, Brennan J,et al. Therapeutic efficacy of ...
  • Silveira SAd. Caracterização de subpopulações de linfócitos B e funcionalidade ...
  • Peng J. B cells help CD8+ T-cell responses. Blood. 2016; ...
  • Farhat M, Greenaway C, Pai M, et al. False-positive tuberculin ...
  • van Rensburg IC, Loxton AG. Killer (FASL regulatory) B cells ...
  • Walzl G, Ronacher K, Hanekom W, et al. Immunological biomarkers ...
  • Andersen P, Kaufmann SH. Novel vaccination strategies against tuberculosis. Cold ...
  • Lykouras D, Sampsonas F, Kaparianos A, et al. Human genes ...
  • Orme IM, Robinson RT, Cooper AM. The balance between protective ...
  • Gupta N, Kumar R, Agrawal B. New players in immunity ...
  • Junqueira-Kipnis AP, Kipnis A, Jamieson A, , et al. NK ...
  • Millman AC, Salman M, Dayaram YK, et al. Natural killer ...
  • Voskoboinik I, Dunstone MA, Baran K, et al. Perforin: structure, ...
  • Prezzemolo T, Guggino G, La Manna MP, et al. Functional ...
  • Ordway D, Henao-Tamayo M, Harton M, et al. The hypervirulent ...
  • Kozakiewicz L, Phuah J, Flynn J, et al. The role ...
  • Cronan MR, Beerman RW, Rosenberg AF, et al. Macrophage epithelial ...
  • Duque-Correa MA, Kühl AA, Rodriguez PC, et al. Macrophage arginase-1 ...
  • Keikha M, Karbalaei M. Antithetical Effects of MicroRNA Molecules in ...
  • Gallo P, Gonçalves R, Mosser DM. The influence of IgG ...
  • Maglione PJ, Chan J. How B cells shape the immune ...
  • Land J, Abdulahad WH, Sanders J-SF, et al. Regulatory and ...
  • Duddy ME, Alter A, Bar-Or A. Distinct profiles of human ...
  • Lund FE, Randall TD. Effector and regulatory B cells: modulators ...
  • Chuang T-H, Ulevitch RJ. Identification of hTLR10: a novel human ...
  • Chan J, Mehta S, Bharrhan S, et al., editors. The ...
  • Bénard A, Sakwa I, Schierloh P, et al. B cells ...
  • Phuah J, Wong EA, Gideon HP, et al. The Effects ...
  • Costello AdL, Kumar A, Narayan V, et al. Does antibody ...
  • Fletcher HA, Snowden MA, Landry B, et al. T-cell activation ...
  • Babaki MKZ, Taghiabadi M, Soleimanpour S, et al. Mycobacterium tuberculosis ...
  • Demissie A, Leyten EM, Abebe M, et al. Recognition of ...
  • Karbalaei Zadeh Babaki M, Soleimanpour S2, Rezaee SA. Antigen 85 ...
  • van Rensburg IC, Kleynhans L, Keyser A, et al. B‐cells ...
  • du Plessis WJ, Keyser A2, Walzl G, et al. Phenotypic ...
  • Lu LL, Chung AW, Rosebrock TR, et al. A Functional ...
  • Costello AM, Kumar A, Narayan V, et al. Does antibody ...
  • Jacobs AJ, Mongkolsapaya J, Screaton GR, et al. Antibodies and ...
  • Li H, Javid B. Antibodies and tuberculosis: finally coming of ...
  • Onyebujoh PC, Ribeiro I, Whalen CC. Treatment Options for HIV-Associated ...
  • Keikha M, Karbalaei M. Antithetical Effects of MicroRNA Molecules in ...
  • نمایش کامل مراجع